Literature DB >> 2938999

Comparative interactions of streptozotocin and chlorozotocin with DNA of an insulin-secreting cell line (RINr).

B T Mossman, C M Ireland, M Filipak, S LeDoux, G L Wilson.   

Abstract

Both streptozotocin and chlorozotocin, the 2-chloroethyl analogue of streptozotocin, are diabetogenic chemicals in rodents. Although these chemicals are similar structurally, they appear to act on pancreatic B cells via different mechanisms. In studies here, damage and repair of DNA after exposure of an insulin-secreting cell line to streptozotocin and chlorozotocin were assessed by nucleoid sedimentation and alkaline elution. Equitoxic concentrations of streptozotocin and chlorozotocin caused significant single-strand breakage of DNA (p less than 0.005). These lesions were repaired in a time-dependent manner, with most repair completed by 24-h post-exposure to chemicals. Additionally, chlorozotocin caused DNA-DNA and DNA-protein crosslinks in insulinoma cells. When proteinase K was included in the crosslinking assay, a substantial proportion of the chlorozotocin-associated crosslinks proved to be DNA interstrand in nature. Analysis of the amount of interstrand crosslinking in insulinoma cells after exposure to chlorozotocin for 1 h showed that formation of interstrand crosslinks was slow. Increasing amounts appeared over a 24-h period. These results suggest that the formation of irreversible DNA interstrand crosslinks may be a critical factor in cytotoxicity and diabetogenicity caused by chlorozotocin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2938999     DOI: 10.1007/bf02427091

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  20 in total

1.  Fractionation of DNA from mammalian cells by alkaline elution.

Authors:  K W Kohn; L C Erickson; R A Ewig; C A Friedman
Journal:  Biochemistry       Date:  1976-10-19       Impact factor: 3.162

2.  A chemical basis for the antitumor activity of chloroethylnitrosoureas.

Authors:  M Colvin; R B Brundrett; W Cowens; I Jardine; D B Ludlum
Journal:  Biochem Pharmacol       Date:  1976-03-15       Impact factor: 5.858

3.  DNA damage and repair in mouse leukemia L1210 cells treated with nitrogen mustard, 1,3-bis(2-chloroethyl)-1-nitrosourea, and other nitrosoureas.

Authors:  R A Ewig; K W Kohn
Journal:  Cancer Res       Date:  1977-07       Impact factor: 12.701

4.  Effect of poly(ADP-ribose) synthetase inhibitor administration to rats before and after injection of alloxan and streptozotocin on islet proinsulin synthesis.

Authors:  Y Uchigata; H Yamamoto; H Nagai; H Okamoto
Journal:  Diabetes       Date:  1983-04       Impact factor: 9.461

5.  Chemical carcinogenesis in the nervous system. Preferential accumulation of O6-methylguanine in rat brain deoxyribonucleic acid during repetitive administration of N-methyl-N-nitrosourea.

Authors:  G P Margison; P Kleihues
Journal:  Biochem J       Date:  1975-06       Impact factor: 3.857

6.  Phase I trial of chlorozotocin.

Authors:  R J Gralla; C T Tan; C W Young
Journal:  Cancer Treat Rep       Date:  1979-01

7.  Pancreatic beta cell toxicity by streptozotocin anomers.

Authors:  A A Rossini; A A Like; W E Dulin; G F Cahill
Journal:  Diabetes       Date:  1977-12       Impact factor: 9.461

8.  Streptozotocin diabetes. Correlation with extent of depression of pancreatic islet nicotinamide adenine dinucleotide.

Authors:  T Anderson; P S Schein; M G McMenamin; D A Cooney
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

9.  Use of pancreatic beta cells in culture to identify diabetogenic N-nitroso compounds.

Authors:  G L Wilson; B T Mossman; J E Craighead
Journal:  In Vitro       Date:  1983-01

10.  Studies on streptozotocin diabetes.

Authors:  O P Ganda; A A Rossini; A A Like
Journal:  Diabetes       Date:  1976-07       Impact factor: 9.461

View more
  8 in total

1.  The potential mechanism of the diabetogenic action of streptozotocin: inhibition of pancreatic beta-cell O-GlcNAc-selective N-acetyl-beta-D-glucosaminidase.

Authors:  R J Konrad; I Mikolaenko; J F Tolar; K Liu; J E Kudlow
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

2.  EXPERIMENTAL INDUCTION OF TYPE 2 DIABETES MELLITUS AND THE EFFICIENCY OF BARIATRIC SURGERY IN ITS REVERSAL IN RATS.

Authors:  L D Hritcu; D Borcea; E Anton; S Morosan; S Pasca; C Trinca; M C Spataru; F D Petrariu; L C Burtan; A Ciobica; A Curpan; D Timofte
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Apr-Jun       Impact factor: 0.877

3.  Abnormal cell calcium concentrations in cultured bone cells obtained from femurs of obese and noninsulin-dependent diabetic rats.

Authors:  J Levy; I Reid; L Halstad; J R Gavin; L V Avioli
Journal:  Calcif Tissue Int       Date:  1989-02       Impact factor: 4.333

4.  Evaluation of chromosomal instability in diabetic rats treated with naringin.

Authors:  Saleh A Bakheet; Sabry M Attia
Journal:  Oxid Med Cell Longev       Date:  2011-09-20       Impact factor: 6.543

Review 5.  Streptozotocin-induced type 1 diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic β cell glucotoxicity.

Authors:  Jinzi Wu; Liang-Jun Yan
Journal:  Diabetes Metab Syndr Obes       Date:  2015-04-02       Impact factor: 3.168

6.  Resolvin D1 Decreases Severity of Streptozotocin-Induced Type 1 Diabetes Mellitus by Enhancing BDNF Levels, Reducing Oxidative Stress, and Suppressing Inflammation.

Authors:  Siresha Bathina; Undurti N Das
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

Review 7.  Streptozotocin-induced diabetes models: pathophysiological mechanisms and fetal outcomes.

Authors:  D C Damasceno; A O Netto; I L Iessi; F Q Gallego; S B Corvino; B Dallaqua; Y K Sinzato; A Bueno; I M P Calderon; M V C Rudge
Journal:  Biomed Res Int       Date:  2014-05-27       Impact factor: 3.411

8.  Chromatographic and spectroscopic determination of solvent-extracted Lantana camara leaf oil.

Authors:  Adane Adugna Ayalew
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.